Free Access
Reprod. Nutr. Dev.
Volume 42, Number 3, May-June 2002
Page(s) 197 - 216


  1. Abu-Shakra S., Alhalabi M.S., Nachtmaan F.C., Schemidt R.A., Brusilow W.S.A., Anabolic steroids induce injury and apoptosis of differentiated skeletal muscle, J. Neurosci. Res. 47 (1997) 186-197.
  2. Anderson J.E., A role for nitric oxide in muscle repair: nitric oxide-mediated activation of muscle satellite cells, Mol. Biol. Cell 11 (2000) 1859-1874.
  3. Arnold T.E., Worrell R.A., Barth J.L., Morris J., Ivarie R., Dexamethasone-mediated induction of MMTV-myf-5 in DD3 myoblasts increases endogenous myogenin expression but does not transactivate myf-5, Exp. Cell Res. 212 (1994) 321-328.
  4. Bae Y.S., Kang S.W., Seo M.S., Baines I.C., Tekle E., Chock P.B., Rhee S.G., Epidermal growth factor (EGF)-induced generation of hydrogen peroxide, J. Biol. Chem. 272 (1997) 217-221.
  5. Baker A.F., Briehl M.M., Dorr R., Powis P., Decreased antioxidant defence and increased oxidant stress during dexamethasone-induced apoptosis: bcl-2 prevents the loss of antioxidant enzyme activity, Cell Death and Diff. 3 (1996) 207-213.
  6. Ball E.H., Sanwall B.D., A synergistic effect of glucocorticoids and insulin on the differentiation of myoblasts, J. Cell. Physiol. 102 (1980) 27-36.
  7. Barja G., The flux of free radical attack through mitochondrial DNA is related to aging rate, Aging Clin. Exp. Res. 12 (2000) 342-355.
  8. Behl C., Effects of glucocorticoids on oxidative stress-induced hippocampal cell death: implications for the pathogenesis of Alzheimer's disease, Exp. Gerontol. 33 (1998) 689-696.
  9. Briehl M.M., Baker A.F., Modulation of the antioxidant defence as a factor in apoptosis, Cell Death Diff. 3 (1996) 63-70.
  10. Briehl M.M., Cotgrave I.A., Powis P., Downregulation of the antioxidant defence during glucocorticoid-mediated apoptosis, Cell Death Diff. 2 (1995) 41-46.
  11. Cai H., Harrison D.G., Endothelial dysfunction in cardiovascular diseases, The role of oxidant stress, Circ. Res. 87 (2000) 840-844.
  12. Calabrese E.J., Baldwin L.A., Hormesis as a biological hypothesis, Environ. Health Perspect. 106 (1998) 357-362.
  13. Dardevet D., Sornet C., Savary I., Debras E., Patureau Mirand P., Grizard J., Glucocorticoid effects on insulin- and IGF-I-regulated muscle protein metabolism during ageing, J. Endocrinol. 156 (1998) 83-89.
  14. Gardner A.M., Xu F.H., Fady C., Jacoby F.J., Duffey D.C., Tu Y., Lichtenstein A., Apoptotic vs. nonapoptotic cytotoxicity induced by hydrogen peroxide, Free Rad. Biol. Med. 22 (1997) 73-83.
  15. Gruber J., Sgonc R., Hu Y.H., Beug H., Eick G., Thymocyte apoptosis induced by elevated endogenous corticosterone levels, Eur. J. Immunol. 24 (1994) 1115-1121.
  16. Hansen L.L., Ikeda Y., Olsen G.S., Busch A.K., Mosthaf L., Insulin signalling is inhibited by micromolar concentrations of H2O2, J. Biol. Chem. 274 (1999) 25078-25084.
  17. Harman D., Aging: a theory based on free radical and radiation chemistry, J. Gerontol. 11 (1956) 298-300.
  18. Hechter O., Grossman A., Chatterton R.T. Jr., Relationship of dihydroepiandrosterone and cortisol in disease, Med. Hypoth. 49 (1997) 85-91.
  19. Hockenbery D.M., Oltvai Z.N., Yin X.M., Millman L.M., Korsmeyer S.J., Bcl-2 functions in an antioxidant pathway to prevent apoptosis, Cell 75 (1993) 241-251.
  20. Ichimori K., Fukahori M., Nakazawa H., Okamoto K., Nishino T., Inhibition of xanthine oxidase and xanthine dehydrogenase by nitric oxide, J. Biol. Chem. 274 (1999) 7763-7768.
  21. Irani K., Xia Y., Zweier J.L., Sollott S.J., Der C.J., Fearon E.R., Sundaresan M., Finkel T., Goldschmidt-Clermont P.J., Mitogenic signalling mediated by oxidants in Ras-transormed fibroblasts, Science 275 (1997) 1649-1652.
  22. Jacobson M.D., Burne J.F., Raff M.C., Programmed cell death and Bcl-2 protection in the absence of a nucleus, EMBO J. 13 (1994) 1899-1910.
  23. Kalimi M., Shafago Y., Loria R., Padgett D., Regelson W., Anti-glucocorticoid effects of dihydroepiandrosterone (DHEA), Mol. Cell. Biochem. 131 (1994) 99-104.
  24. Kim K.D., Choe Y.K., Choe I.S., Lim J.S., Inhibition of glucocorticoid-mediated, caspase-independent dendritic cell death by CD40 activation, J. Leukoc. Biol. 69 (2001) 426-434.
  25. Landfield P.W., Eldridge J.C., The glucocorticoid hypothesis of age-related hippocampal neurodegeneration: role of dysregulated intraneuronal calcium, Ann. N. Y. Acad. Sci. 746 (1994) 308-321.
  26. Landfield P.W., Eldridge J.C., Evolving aspects of the glucocorticoid hypothesis of brain aging: hormonal modulation of neuronal calcium homeostasis, Neurobiol. Aging. 15 (1994) 579-588.
  27. Leist M., Single B., Naumann H., Fava E., Simon B., Kuhnle S., Nicotera P., Nitric oxide inhibits execution of apoptosis at two distinct ATP-dependent steps upstream and downstream of mitochondrial cytochrome c release, Biochem. Biophys. Res. Commun. 258 (1999) 215-221.
  28. Li Z.W., Chu W., Hu Y., Delhase M., Deerinck T., Ellisman M., Johnson R., Karin M., The IKK$\beta$ subunit of I$\kappa$B kinase (IKK) is essential for NF-$\kappa$ B activation and prevention of apoptosis, J. Exp. Med. 189 (1999) 1839-1845.
  29. Marshall C.J., Specificity of receptor tyrosine kinase signalling: transient versus sustained extracellular signal-regulated kinase activation, Cell 80 (1995) 179-185.
  30. Meagher L.C., Cousin J.M., Seckl J.R., Haslett C., Opposing effects of glucocorticoids on the rate of apoptosis in neutrophilic and eosinophilic granulocytes, J. Immunol. 156 (1996) 4422-4428.
  31. Miguel J., Economos A.C., Mitochondrial role in cell aging, Exp. Gerontol. 15 (1980) 575-591.
  32. Mohr S., Zech B., Lapetina E.G., Brune B., Inhibition of caspase-3 by S-nitrosation and oxidation caused by nitric oxide, Biochem. Biophys. Res. Commun. 238 (1997) 387-391.
  33. Morel Y., Barouki R., Repression of gene expression by oxidative stress, Biochem. J. 342 (1999) 481-496.
  34. Orzechowski A., Ostaszewski P., Brodnicka A., Wilczak J., Jank M., Balasilska B., Grzelkowska K., Ploszaj T., Olczak J., Mrówczylska A., Excess of glucocorticoids impairs whole body antioxidant status in young rats. Relation to the effect of dexamethasone in soleus muscle and spleen, Horm. Metab. Res. 32 (2000) 174-180.
  35. Pfeiffer S., Mayer B., Hemmens B., Nitric oxide: chemical puzzles posed by a biological messenger, Angew. Chemistry Int. Ed. 38 (1999) 1714-1731.
  36. Roymans D., Slegers H., Phosphatidylinositol 3-kinases in tumor progression, Eur. J. Biochem. 268 (2001) 487-498.
  37. Sainz R.M., Mayo J.C., Reiter R.J., Antolin I., Esteban M.M., Rodriguez C., Melatonin regulates glucocorticoid receptor: an answer to its antiapoptotic action in thymus, FASEB J. 13 (1999) 1547-1556.
  38. Sanderson J., Marcantonio J.M., Duncan G., A human lens model of cortical cataract: Ca2+-induced protein loss, vimentin cleavage and opacification, Invest. Ophtalmol. Vis. Sci. 41 (2000) 2255-2261.
  39. Sarbassov D.D., Peterson C.A., Insulin receptor substrate-1 and phosphatidylinositol 3-kinase regulate extracellular signal-regulated kinase-dependent and -independent signalling pathways during myogenic differentiation, Mol. Endocrinol. 12 (1998) 1870-1878.
  40. Sarbassov D.D., Jones L.G., Peterson C.A., Extracellular signal-regulated kinase-1 and -2 respond differently to mitogenic and differentiative signalling pathways in myoblasts, Mol. Endocrinol. 11 (1997) 2038-2047.
  41. Schlessinger J., Cell signalling by receptor tyrosine kinases, Cell 103 (2000) 211-225.
  42. Sundaresan M., Yu Z.X., Ferrans V.J., Sulciner D.J., Gutkind J.S., Irani K., Goldschmidt- Clermont P.J., Finkel T., Regulation of reactive-oxygen-species generation in fibroblasts by Rac1, Biochem. J. 318 (1996) 379-382.
  43. Thompson E.B., Apoptosis and steroid hormones, Mol. Endocrinol. 8 (1994) 665-673.
  44. Tome M.E., Baker A.F., Powis G., Payne C.M., Briehl M.M., Catalase-overexpressing thymocytes are resistant to glucocorticoid-induced apoptosis and exhibit increased net tumor growth, Cancer Res. 61 (2001) 2766-2773.
  45. Tournier C., Thomas G., Pierre J., Jacquemin C., Pierre M., Saunier B., Mediation by arachidonic acid metabolites of the H2O2-induced stimulation of mitogen-activated protein kinases (extracellular-signal-regulated kinase and c-Jun NH2-terminal kinase), Eur. J. Biochem. 244 (1997) 587-595.
  46. Weinstein R.S., Jilka R.L., Parfitt A.M., Manolagas S.C., Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone, J. Clin. Invest. 102 (1998) 274-282.
  47. Yeh L.H., Park Y.J., Hansalia R.J., Ahmed I.S., Dehspande S.S., Goldsmidt-Clermont P.J., Irani K., Alevriadou B.R., Shear-induced tyrosine phosphorylation in endothelial cells requires Rac-1-dependent production of ROS, Am. J. Physiol. (Cell Physiol.) 276 (1998) C838-C847.
  48. Zacharchuk C.M., Mercep M., Chakraborti P.K., Simons S.S. Jr., Ashwell J.D., Programmed T lymphocyte death. Cell activation- and steroid-induced pathways are mutually antagonistic, J. Immunol. 145 (1990) 4037-4045.


Copyright INRA, EDP Sciences